Idelalisib is a pharmaceutical compound used as an active pharmaceutical ingredient. It is a phosphoinositide 3-kinase inhibitor that blocks the delta isoform of the enzyme, with a structure characterized by multiple aromatic rings and an amine group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Idelalisib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Leptomycin A
pharmaceutical raw material
Evocalcet
pharmaceutical raw material
Raltegravir potassium
pharmaceutical raw material
Trametinib
pharmaceutical raw material
The international HS code for Idelalisib (CAS 870281-82-6) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
5-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-4-one
IFSDAJWBUCMOAH-HNNXBMFYSA-N
CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5
Sourcing Idelalisib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.